Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Gatifloxacin 400 mg/Day	10
Overall Study	STARTED	Levofloxacin 1000 mg/Day	10
Overall Study	STARTED	Linezolid 600 mg / Once Daily	10
Overall Study	STARTED	Linezolid 600 mg / Twice Daily	10
Overall Study	STARTED	Moxifloxacin 400 mg/Day	10
Overall Study	STARTED	Isoniazid (INH) 300 mg/Day	20
Overall Study	COMPLETED	Gatifloxacin 400 mg/Day	10
Overall Study	COMPLETED	Levofloxacin 1000 mg/Day	10
Overall Study	COMPLETED	Linezolid 600 mg / Once Daily	10
Overall Study	COMPLETED	Linezolid 600 mg / Twice Daily	9
Overall Study	COMPLETED	Moxifloxacin 400 mg/Day	9
Overall Study	COMPLETED	Isoniazid (INH) 300 mg/Day	18
Overall Study	NOT COMPLETED	Gatifloxacin 400 mg/Day	0
Overall Study	NOT COMPLETED	Levofloxacin 1000 mg/Day	0
Overall Study	NOT COMPLETED	Linezolid 600 mg / Once Daily	0
Overall Study	NOT COMPLETED	Linezolid 600 mg / Twice Daily	1
Overall Study	NOT COMPLETED	Moxifloxacin 400 mg/Day	1
Overall Study	NOT COMPLETED	Isoniazid (INH) 300 mg/Day	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00396084/flow